Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis : a cohort study
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 83(2024), 5 vom: 11. Apr., Seite 680-682 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schiff, Abigail E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Electronic UpdateOf: medRxiv. 2023 Oct 09;:. - PMID 37873462 Citation Status MEDLINE |
|---|
| doi: |
10.1136/ard-2023-225162 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366903853 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366903853 | ||
| 003 | DE-627 | ||
| 005 | 20240415233106.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/ard-2023-225162 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM366903853 | ||
| 035 | |a (NLM)38199795 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schiff, Abigail E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis |b a cohort study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.04.2024 | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a UpdateOf: medRxiv. 2023 Oct 09;:. - PMID 37873462 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Arthritis, Rheumatoid | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Rituximab | |
| 650 | 4 | |a Vaccination | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a mRNA Vaccines |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Wang, Xiaosong |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Naomi J |e verfasserin |4 aut | |
| 700 | 1 | |a Kawano, Yumeko |e verfasserin |4 aut | |
| 700 | 1 | |a Hanberg, Jennifer L |e verfasserin |4 aut | |
| 700 | 1 | |a Kowalski, Emily N |e verfasserin |4 aut | |
| 700 | 1 | |a Cook, Claire E |e verfasserin |4 aut | |
| 700 | 1 | |a Vanni, Kathleen Mm |e verfasserin |4 aut | |
| 700 | 1 | |a Qian, Grace |e verfasserin |4 aut | |
| 700 | 1 | |a Bade, Katarina J |e verfasserin |4 aut | |
| 700 | 1 | |a Saavedra, Alene A |e verfasserin |4 aut | |
| 700 | 1 | |a Srivatsan, Shruthi |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Zachary K |e verfasserin |4 aut | |
| 700 | 1 | |a Venkat, Rathnam K |e verfasserin |4 aut | |
| 700 | 1 | |a Wallace, Zachary S |e verfasserin |4 aut | |
| 700 | 1 | |a Sparks, Jeffrey A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 83(2024), 5 vom: 11. Apr., Seite 680-682 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2024 |g number:5 |g day:11 |g month:04 |g pages:680-682 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/ard-2023-225162 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2024 |e 5 |b 11 |c 04 |h 680-682 | ||